Effectiveness and Utility of Telemonitoring in Improving the Glycaemic Control of Diabetes Mellitus Tunisian Patients
NCT07774078
Summary
The study aims to evaluate the impact of a telemonitoring system on glycemic control in patients with diabetes in Tunisia. Participants in the intervention group will receive remote diabetes management through a dedicated mobile application and web platform, while the control group will receive standard diabetes care. The primary objective is to determine the effectiveness of telemonitoring in improving glycemic control, as assessed by changes in glycated hemoglobin (HbA1c) and blood glucose levels.
Eligibility
Inclusion Criteria: * Diagnosis of diabetes mellitus with HbA1c between 7% and 10%. * Stable antidiabetic treatment for at least 4 weeks prior to enrollment. Exclusion Criteria: * Serum creatinine \>200 µmol/L. * Acute coronary syndrome or stroke. * Dementia. * Pregnancy. * Inability to participate in or comply with the telemonitoring intervention. * Severe diabetic retinopathy.
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07774078